Vulcan Energy appoints lithium expert to lead its team in Germany

|

Published 31-MAY-2021 11:34 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Vulcan Energy (ASX:VUL) has appointed one of the world’s leading experts in lithium extraction from geothermal brines.

Dr. Stephen Harrison has been appointed by VUL as Chief Technical Officer (CTO).

Dr Harrison has thorough knowledge of all steps of industry process/product commercialisation in the lithium industry dating back to 1998. He holds a PhD Chemical Engineering from the University of Newcastle-upon-Tyne and Master of Science (M.Sc.), Electrochemical Science, from the University of Southampton.

Dr Harrison will lead the company’s lithium team in Germany, where his experience will be invaluable to VUL’s overall operations.

VUL is aiming to become the world’s first lithium producer with net zero greenhouse gas emissions.

Its ZERO CARBON LITHIUMTM project will produce a battery-quality lithium hydroxide chemical product from its combined geothermal energy and lithium resource, which is Europe’s largest lithium resource, in Germany.

Vulcan’s unique, ZERO CARBON LITHIUMTM project will produce both renewable geothermal energy, and lithium hydroxide, from the same deep brine source.

Dr Harrison will play a crucial role in helping VUL achieve this aim.

Dr. Stephen Harrison will join VUL as CTO, leading VUL's team in Germany.
Dr. Stephen Harrison will join VUL as CTO, leading VUL's team in Germany.

His CV is impressive:

  • Dr. Harrison was CTO of Simbol Materials for seven years (2008- 2015), where he led the scientific and engineering teams through a rapid process development, taking less than one year to develop a process to extract lithium from geothermal brine, which is today recognised as the lowest cost production method to lithium hydroxide.
  • As CEO of Rakehill Technology LLC, Dr. Harrison has since consulted to the lithium industry on various lithium extraction technologies including sorbents.

Vulcan hopes to address EU market requirements for lithium by reducing the high carbon and water footprint of production, and total reliance on lithium imports.

Vulcan aims to supply the lithium-ion battery and electric vehicle market in Europe, which is the fastest growing in the world. The Vulcan Zero Carbon LithiumTM project has a resource which can satisfy Europe’s needs for the electric vehicle transition, from a source with net zero greenhouse gas emissions, for many years to come.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X